InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,433.74
(
0.23%
)
US TECH 100
19,068.80
(
0.00%
)
Dow Jones
38,647.10
(
-0.17%
)
Brent Oil
82.23
(
0.30%
)
Bitcoin
66,909.66
(
0.23%
)
Post# of 32016
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DownWithPumpers

Send PM Follow Ignore
Followers 83
Posts 5662
Boards Moderated 1
Alias Born 10/17/2006

DownWithPumpers

Re: bakersson post# 22549

Friday, 04/21/2017 8:54:13 AM

Friday, April 21, 2017 8:54:13 AM

Post# of 32016
There's lots of good that you can say from the FDA study. Afrezza more closely replicates the natural mealtime insulin response of the pancreas than any other drug in the marketplace. Afrezza doesn't have 1/10 the harmful side effects of many drugs routinely appearing on ads on TV.

The FDA trial documented more than one side effect per patient.

It didn't conclude that Afrezza "more closely replicates the natural mealtime insulin response of the pancreas".

None of that can legally appear in any advertisement.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MNKD News
More MNKD News
InvestorsHub NewsWire

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM

HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM

Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM

Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM

Start posting your company's news
Only $200 per official company press release!